A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials
CONCLUSIONS: Empagliflozin is the first treatment with established efficacy and cost-effectiveness for HF patients across EF from the perspective of healthcare payers in Spain. Empagliflozin also proved to be cost-effective for all subgroups of patients included in the analysis.PMID:38416135 | DOI:10.1080/14779072.2024.2324027 (Source: Expert Review of Cardiovascular Therapy)
Source: Expert Review of Cardiovascular Therapy - February 28, 2024 Category: Cardiology Authors: Xavier Garc ía-Moll Francesco Croci Alexandra Sol é Elisabeth S Hartgers-Gubbels Miguel A Calleja-Hern ández Source Type: research

Original algorithms for the detection of cardiovascular involvement of neglected tropical diseases
Expert Rev Cardiovasc Ther. 2024 Feb 26:1-16. doi: 10.1080/14779072.2024.2315090. Online ahead of print.ABSTRACTINTRODUCTION: Neglected tropical diseases (NTDs) introduce considerable morbidity and mortality on a global scale, directly impacting over 1 billion individuals as well as their families and communities. Afflicted individuals may have limited access to resources and care in these regions, contributing to a high proportion of chronic, progressive, and systemic disease. The cardiovascular system is at particular risk of demise for several NTDs, yet remains largely unstudied due in part to the lack of robust data co...
Source: Expert Review of Cardiovascular Therapy - February 3, 2024 Category: Cardiology Authors: Kiera Liblik Ioana Tereza Florica Adrian Baranchuk Source Type: research

Original algorithms for the detection of cardiovascular involvement of neglected tropical diseases
Expert Rev Cardiovasc Ther. 2024 Feb 3. doi: 10.1080/14779072.2024.2315090. Online ahead of print.ABSTRACTINTRODUCTION: Neglected tropical diseases (NTDs) introduce considerable morbidity and mortality on a global scale, directly impacting over 1 billion individuals as well as their families and communities. Afflicted individuals may have limited access to resources and care in these regions, contributing to a high proportion of chronic, progressive, and systemic disease. The cardiovascular system is at particular risk of demise for several NTDs, yet remains largely unstudied due in part to the lack of robust data collecti...
Source: Expert Review of Cardiovascular Therapy - February 3, 2024 Category: Cardiology Authors: Kiera Liblik Ioana Tereza Florica Adrian Baranchuk Source Type: research

The clinical characteristics, managements, and outcomes of acute myocardial infarction in osteoarthritis patients; a cross-sectional analysis of 6.5 million patients
CONCLUSIONS: This study of a representative sample of the US population highlights that OA patients are less likely to be offered invasive interventions following AMI. OA was also associated with better outcomes post-AMI, possibly attributed to a misclassification bias where unwell patients with OA were less likely to receive an OA code because codes for serious illness took precedence.PMID:38284347 | DOI:10.1080/14779072.2024.2311696 (Source: Expert Review of Cardiovascular Therapy)
Source: Expert Review of Cardiovascular Therapy - January 29, 2024 Category: Cardiology Authors: Simran Singh Parmar Mohamed O Mohamed Mamas A Mamas Ross Wilkie Source Type: research

Sex differences in trends and outcomes of acute myocardial infarction with mechanical complications in the United States
CONCLUSION: Despite the decreasing trend in AMI admission, females had higher risk of MC and associated mortality. Significant sex disparities still exist in AMI treatment.PMID:38284754 | DOI:10.1080/14779072.2024.2311707 (Source: Expert Review of Cardiovascular Therapy)
Source: Expert Review of Cardiovascular Therapy - January 29, 2024 Category: Cardiology Authors: Frederick Berro Rivera Faye Salva Jacques Simon Gonzales Sung Whoy Cha Samantha Tang Grace Nooriza Opay Lumbang Gurleen Kaur Isabel Planek Kyla Lara-Breitinger Mark Dela Cruz Tisha Marie B Suboc Fareed Moses S Collado Jonathan R Enriquez Nishant Shah Anna Source Type: research

Preventive cardiology for the aging population: how can we better design clinical trials of statins?
Expert Rev Cardiovasc Ther. 2024 Jan 23:1-6. doi: 10.1080/14779072.2024.2302122. Online ahead of print.ABSTRACTINTRODUCTION: Older adults form a fast-increasing proportion of the world population. However, gains in increasing quantity of life have not been accompanied by similar gains in quality of life. Older people frequently experience frailty, memory problems, and chronic diseases including cardiovascular disease (CVD) and neurodegenerative diseases. Recent trials have demonstrated the efficacy of anti-hypertensive therapy in older populations but failed to show benefits for aspirin.AREA COVERED: Statins clearly reduce...
Source: Expert Review of Cardiovascular Therapy - January 23, 2024 Category: Cardiology Authors: Anthony S Wierzbicki Source Type: research

Trends and cardiovascular outcomes of Takotsubo syndrome with cardiogenic shock vs. mixed cardiogenic and septic shock: a nationwide propensity matched analysis
CONCLUSION: MS in the setting of TTS have higher rates of in-hospital mortality, AKI, and pressor requirements.PMID:38105722 | DOI:10.1080/14779072.2023.2295378 (Source: Expert Review of Cardiovascular Therapy)
Source: Expert Review of Cardiovascular Therapy - December 18, 2023 Category: Cardiology Authors: Sadaf Fakhra Mohammed Faisaluddin Yasar Sattar Danielle DeCicco Asmaa Ahmed Neel Patel Senthil Balasubramanian Dipesh Ludhwani Hassan Masood Sameer Raina Karthik Gonuguntla Scott C Feitell Tushar Tarun Sudarshan Balla Source Type: research